CARs can recognize a wide range of cell surface antigens, including glycolipids, carbohydrates, and proteins derived from tumors in a non-MHC-restricted manner which helps overcome MHC downregulation as a mechanism of tumor escape. This evidence concerns the gene HLA-C and neoplasm.